IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Asston Pharmaceuticals IPO listing price is ₹ 119.00, issue price is ₹ 123.00, and currently trading at ₹ 112.00 as on August 7, 2025. Asston Pharmaceuticals IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Asston Pharmaceuticals IPO is a Book Building listing on BSE SME exchange. The company is based in Mumbai and caters to Pharmaceutical sector. Sobhagya Capital Options is the merchant banker of Asston Pharmaceuticals IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 16th January 2025.
Asston Pharmaceuticals IPO offer price is ₹ 123.00 and got listed at ₹ 119.00. Read Asston Pharmaceuticals IPO details mentioned above.The IPO of Asston Pharmaceuticals Limited was listed on 16th July 2025. As of today, Asston Pharmaceuticals IPO is trading at ₹ 112.00, compared to the previous day’s close of ₹ 115.55. Read the report above for detailed IPO performance.
The issue price of Asston Pharmaceuticals IPO was ₹ 123.00 per equity share.
Asston Pharmaceuticals IPO was listed at ₹119.00 on the stock exchange on 16th July 2025. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of August 7, 2025, the current market price of Asston Pharmaceuticals IPO is ₹ 112.00.
The 52-week high for Asston Pharmaceuticals IPO is ₹ 126.00, while the 52-week low is ₹ 107.35. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Asston Pharmaceuticals IPO listed at ₹ 119.00 against the issue price of ₹ 123.00 per equity share, showing a listing day gain/loss of -4 (-3.25%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Asston Pharmaceuticals IPO stock moved from its listing price of ₹ 119.00 to the current price of ₹112.00 per equity share, reflecting a change of -5.88% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Asston Pharmaceuticals IPO issue date of 16th July 2025 and CMP of ₹112.00, the estimated CAGR is approximately -77.39%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
₹ 123.00
Listing Price :
₹ 119.00
Previous Day Closing
₹ 115.55
Asston Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Asston Pharmaceuticals Financial Review Page
Merchant Banker(s) of Asston Pharmaceuticals IPO: Sobhagya Capital Options Limited
Asston Pharmaceuticals IPO subscription was 186.55 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Asston Pharmaceuticals IPO listed at a listing price of 119.00 against the offer price of 123.00.
The current market price of Asston Pharmaceuticals is 112.00.
Why Us?
